Biochemistry

Structural bioinformatics-based design of selective, irreversible kinase inhibitors

Michael Cohen, Chao Zhang, Kevan M. Shokat, Jack Taunton

Research output: Contribution to journalArticle

346 Citations (Scopus)

Abstract

The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.

Original languageEnglish (US)
Pages (from-to)1318-1321
Number of pages4
JournalScience
Volume308
Issue number5726
DOIs
StatePublished - May 27 2005
Externally publishedYes

Fingerprint

Ribosomal Protein S6 Kinases
Computational Biology
Biochemistry
Protein Kinases
Catalytic Domain
90-kDa Ribosomal Protein S6 Kinases
Phosphotransferases
Threonine
Cysteine
Amino Acids
Protein Domains

ASJC Scopus subject areas

  • General

Cite this

Biochemistry : Structural bioinformatics-based design of selective, irreversible kinase inhibitors. / Cohen, Michael; Zhang, Chao; Shokat, Kevan M.; Taunton, Jack.

In: Science, Vol. 308, No. 5726, 27.05.2005, p. 1318-1321.

Research output: Contribution to journalArticle

Cohen, Michael ; Zhang, Chao ; Shokat, Kevan M. ; Taunton, Jack. / Biochemistry : Structural bioinformatics-based design of selective, irreversible kinase inhibitors. In: Science. 2005 ; Vol. 308, No. 5726. pp. 1318-1321.
@article{8854cdeed169403ebeadd303a8ee1f0d,
title = "Biochemistry: Structural bioinformatics-based design of selective, irreversible kinase inhibitors",
abstract = "The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.",
author = "Michael Cohen and Chao Zhang and Shokat, {Kevan M.} and Jack Taunton",
year = "2005",
month = "5",
day = "27",
doi = "10.1126/science1108367",
language = "English (US)",
volume = "308",
pages = "1318--1321",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5726",

}

TY - JOUR

T1 - Biochemistry

T2 - Structural bioinformatics-based design of selective, irreversible kinase inhibitors

AU - Cohen, Michael

AU - Zhang, Chao

AU - Shokat, Kevan M.

AU - Taunton, Jack

PY - 2005/5/27

Y1 - 2005/5/27

N2 - The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.

AB - The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.

UR - http://www.scopus.com/inward/record.url?scp=19744364796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19744364796&partnerID=8YFLogxK

U2 - 10.1126/science1108367

DO - 10.1126/science1108367

M3 - Article

VL - 308

SP - 1318

EP - 1321

JO - Science

JF - Science

SN - 0036-8075

IS - 5726

ER -